APA (7th ed.) Citation

FA, B., BS, A., NI, Z., AA, A., ST, A., MK, E., . . . HA, A. (2024). Molecular docking, DFT and antiproliferative properties of 4-(3,4-dimethoxyphenyl)-3-(4-methoxyphenyl)-1-phenyl-1H-pyrazolo[3,4-b]pyridine as potent anticancer agent with CDK2 and PIM1 inhibition potency. Drug development research, 85(7), e70009. https://doi.org/10.1002/ddr.70009

Chicago Style (17th ed.) Citation

FA, Binjubair, Almansour BS, Ziedan NI, Abdel-Aziz AA, Al-Rashood ST, Elgohary MK, Elkotamy MS, and Abdel-Aziz HA. "Molecular Docking, DFT and Antiproliferative Properties of 4-(3,4-dimethoxyphenyl)-3-(4-methoxyphenyl)-1-phenyl-1H-pyrazolo[3,4-b]pyridine as Potent Anticancer Agent with CDK2 and PIM1 Inhibition Potency." Drug Development Research 85, no. 7 (2024): e70009. https://doi.org/10.1002/ddr.70009.

MLA (9th ed.) Citation

FA, Binjubair, et al. "Molecular Docking, DFT and Antiproliferative Properties of 4-(3,4-dimethoxyphenyl)-3-(4-methoxyphenyl)-1-phenyl-1H-pyrazolo[3,4-b]pyridine as Potent Anticancer Agent with CDK2 and PIM1 Inhibition Potency." Drug Development Research, vol. 85, no. 7, 2024, p. e70009, https://doi.org/10.1002/ddr.70009.